Twist Total Current Liabilities from 2010 to 2024
| TWST Stock | USD 41.36 1.73 4.01% |
Total Current Liabilities | First Reported 2016-09-30 | Previous Quarter 65.2 M | Current Value 67.5 M | Quarterly Volatility 27.2 M |
Check Twist Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Twist main balance sheet or income statement drivers, such as Tax Provision of 1.1 M, Net Interest Income of 17.3 M or Interest Income of 17.3 M, as well as many exotic indicators such as Price To Sales Ratio of 5.14, Dividend Yield of 0.0 or PTB Ratio of 1.9. Twist financial statements analysis is a perfect complement when working with Twist Bioscience Valuation or Volatility modules.
Twist | Total Current Liabilities |
Latest Twist Bioscience's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Twist Bioscience Corp over the last few years. Total Current Liabilities is an item on Twist Bioscience balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Twist Bioscience Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Twist Bioscience's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Twist Bioscience's overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Twist Total Current Liabilities Regression Statistics
| Arithmetic Mean | 33,547,666 | |
| Geometric Mean | 21,942,760 | |
| Coefficient Of Variation | 90.71 | |
| Mean Deviation | 25,532,399 | |
| Median | 18,537,000 | |
| Standard Deviation | 30,431,481 | |
| Sample Variance | 926.1T | |
| Range | 82M | |
| R-Value | 0.84 | |
| Mean Square Error | 293.4T | |
| R-Squared | 0.71 | |
| Significance | 0.000088 | |
| Slope | 5,716,837 | |
| Total Sum of Squares | 12965.1T |
Twist Total Current Liabilities History
About Twist Bioscience Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Twist Bioscience income statement, its balance sheet, and the statement of cash flows. Twist Bioscience investors use historical funamental indicators, such as Twist Bioscience's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Twist Bioscience investors may use each financial statement separately, they are all related. The changes in Twist Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Twist Bioscience's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Twist Bioscience Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Twist Bioscience. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 84.3 M | 45.4 M |
Pair Trading with Twist Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Twist Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Twist Bioscience will appreciate offsetting losses from the drop in the long position's value.Moving together with Twist Stock
| 0.77 | PFE | Pfizer Inc Financial Report 6th of August 2024 | PairCorr |
Moving against Twist Stock
| 0.49 | CVS | CVS Health Corp | PairCorr |
| 0.45 | INDP | Indaptus Therapeutics | PairCorr |
| 0.43 | FBRX | Forte Biosciences | PairCorr |
The ability to find closely correlated positions to Twist Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Twist Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Twist Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Twist Bioscience Corp to buy it.
The correlation of Twist Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Twist Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Twist Bioscience Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Twist Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Twist Bioscience Correlation against competitors. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Twist Stock analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.36) | Revenue Per Share 4.834 | Quarterly Revenue Growth 0.251 | Return On Assets (0.16) | Return On Equity (0.30) |
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.